Bilayer tablet overview: A revolutionary approach in sustained drug release & combination drug therapy
DOI:
https://doi.org/10.56511/JIPBS.2023.10302Abstract
A fresh method of administering drug, the bilayer tablet is a single dosage form containing 2 or more Active Pharmaceutical Ingredients (API). By incorporating two distinct layers, bilayer tablets provide improved drug release profiles and enhanced therapeutic efficacy. This review's objective is to pinpoint the challenges that arise when making bilayer tablets and to suggest solutions for these difficulties. To help you better grasp bilayer tablets, types like double side presses, single side presses, and bilayer tablet displacement presses are discussed along with their uses, advantages, and disadvantages. In this thorough guide, we will look into the design, manufacturing, and applications of bilayer tablets
Keywords:
Bilayer tablet, Combination drug therapy, Sustained release, Double compressionDownloads
References
Abebe A, Akseli I, Sprockel O, Kottala N, Cuitiño AM. Review of bilayer tablet technology. International journal of pharmaceutics. 2014; 461(1 - 2):549 - 58.
Akhtar M, Jamshaid M, Zaman M, Mirza AZ. Bilayer tablets: A developing novel drug delivery system. Journal of Drug Delivery Science and Technology. 2020; 60:102079.
Singh A, Das S, Gupta S, Ghosh S. The Challenges of Producing Bilayer Tablet: A Review. Journal of Drug Delivery and Therapeutics. 2021; 11(4 - S):171 - 5 .
Simão J, Chaudhary SA, Ribeiro AJ. Implementation of Quality by Design (QbD) for Development of Bilayer Tablets. European Journal of Pharmaceutical Sciences. 2023 ; 106412. Hypertension and biphasic release profile (39) synergistic effect Synergistic effect for pain (40)
Kottala N, Abebe A, Sprockel O, Bergum J, Nikfar F, Cuitiño AM. Evaluation of the performance characteristics of bilayer tablets: Part II. Impact of environmental conditions on the strength of bilayer tablets. AAPS PharmSciTech. 2012;13(4):1190 - 6.
Kottala N, Abebe A, Sprockel O, Bergum J, Nikfar F, Cuitiño AM. Evaluation of the performance characteristics of bilayer tablets: Part I. Impact of material properties and process parameters on the strength of bilayer tablets. AAPS PharmSciTech. 2012;13(4):1236 - 42.
Kale PS, Ghadge PS, Bobde MN, Shahi SR. Overview of bilayer tablet: A Review. International Journal for Research Trends and Innovation.2022; (6):697 - 707
Chapagain B, Vandana S, Patil S. Review on Bilayer Oral Dosage Form with Immediate and Sustained Release Layers. Latin American Journal of Pharmacy: A Life Science Journal. 2023; 42(5):169 - 79.
Ahuja N, Kumar V, Rathee P. Osmotic - controlled release oral delivery system: An advanced oral delivery form. The Pharma Innovation. 2012; 1(7) :116 - 24.
Liu L, Xu X. Preparation of bilayer - core osmotic pump tablet by coating the indented core tablet. International journal of pharmaceutics. 2008; 352(1 - 2):225 - 30 .
Sarma A, Deb P, Dash S. Bilayer tablet and duredas technology – a review. International Journal of Pharmacy and Biological Sciences. 2013; 3(2):554 - 63.
Kale SS, Saste VS, Ughade PL, Baviskar DT. Bilayer tablet. International Journal of Pharmaceutical Sciences Review and Research. 2011; 9(1):25 - 30.
Sarma A, Deb P, Dash S. Bilayer tablet and duredas technology – a review. International Journal of Pharmacy and Biological Sciences. 2013; 3(2):554 - 63.
Chakka PG, Bindu VH, Nischala M. An Overview on Bilayered Tablet Technology. Journal of Global Trends in Pharmaceutical Sciences. 2013; 4(2).
Deshpande RD, Gowda DV, Mahammed N, Maramwar DN. Bi - layer tablets - An emerging trend: a review. International journal of pharmaceutical sciences and research. 2011; 2(10):2534.
Kumar Verma N, Roshani K, Panda P, Vishwakarma DK. A brief review on bilayer floating tablet. 2017; 06(03): 1077 - 1085.
Jyoti Das R, Pathak K, Mazumder B. Chapter - 3 Advancement in Bilayer Tablet Technology as a Novel Drug Delivery System. 2023; 1(7):41 - 63 .
Dey S, Chattopadhyay S, Mazumder B. Formulation and evaluation of fixed - dose combination of bilayer gastroretentive matrix tablet containing atorvastatin as fast - release and atenolol as sustained - release. BioMed Research International. 2014; 2014.
Maddiboyina B, Hanumanaik M, Nakkala RK, Jhawat V, Rawat P, Alam A, Foudah AI, Alrobaian MM, Shukla R, Singh S, Kesharwani P. Formulation and evaluation of gastro - retentive floating bilayer tablet for the treatment of hypertension. Heliyon. 2020; 6(11).
Hu L, Hu Q, Kong D. formulation and in vitro evaluation of aspirin and isosorbide 5 - mono - nitrate sustained bilayer tablets. International Journal of Pharmacy & Life Sciences. 2014; 5(3).
Sharma SK, Mohan S, Jaimini M, Chauhan BS, Chatterjee A. Formulation and in - vitro evaluation of Bilayer tablets containing Pioglitazone HCl and Gliclazide for type II diabetes. International Journal of PharmTech Research. 2014; 6(2):607 - 22
Todicherla VKS, Parimi N, Cherukuri M. Development of formulation and in - vitro evaluation of buccoadhesive tablets of losartan potassium. International Journal of PharmTech Research. 2013; 5(4). 828 - 1838.
Saif AA, Alburyhi MM, Noman MA, Almaktari A. Formulation and evaluation of trimetazidine hydrochloride and clopidogrel bisulphate multi - unit solid dosage forms. Journal of Chemical and Pharmaceutical Research. 2014; 6(2):421 - 6.
Jamunadhevi V, Sahoo PK, Kailasam P. Formulation and in vitro evaluation of bi - layer tablet of cyclobenzaprine hydrochloride ER and diclofenac potassium IR - A novel fixed dose combination. Int J Res Pharm Sci. 2011; 2(2):170 - 8.
Pv Swamy, Kinagi M, Biradar S, Gada S, Shilpa H. Formulation design and evaluation of bilayer buccal tablets of granisetron hydrochloride. Ind J Pharm Edu Res. 2011; 45(3):242.
Jain J, Marya BH, Mittal RP, Patel M. Formulation and evaluation of indomethacin bilayer sustained release tablets. Int J PharmTech Res. 2011; 3(2):1132 - 8.
Pattanayak DP, Dinda SC. Bilayer tablet formulation of metformin hydrochloride and glimepiride: A novel approach to improve therapeutic efficacy. Int. J. Drug Discov. Herb. Res. 2011 ; 1:1 - 4.
Mohindeen S, Jyothi B, Pavani S, Satyanarayana T, Kumar SP, Krishna NS. Formulation and evaluation of bilayered tablets of metformin hydrochloride and atorvastatin calcium. Int J Pharm Sci Rev Res. 2011; 10(2):130 - 4.
Kumar GV, Babu KA, Ramasanay C. Formulation and evaluation of bilayered tablets of cefixime trihydrate and dicloxacillin sodium. Int J PharmTech Res. 2011; 3(2):613 - 8.
Jadhav RT, Patil PH, Patil PR. Formulation and evaluation of bilayered tablet of Piracetam and Vinpocetine. J Chem Pharm Res. 2011; 3(3):423 - 31
Shirsand SB, Swamy PV, Keshavshetti GG. Design and evaluation of atenolol bilayer buccal tablets. RJPS. 2011; 1(1):1.
Dhumal RS, Rajmane ST, Dhumal ST, Pawar AP. Design and evaluation of bilayer floating tablets of cefuroxime axetil for bimodal release. J Sci Ind Res (India). 2006; 65(10).
Jayaprakash S, Halith SM, Pillai KK, Balasubramaniyam P, Firthouse PM, Boopathi M. Formulation and evaluation of bilayer tablets of amlodipine besilate and metprolol succinate. Der Pharmacia Lettre. 2011; 3(4):143 - 54.
Gohel MC, Parikh RK, Nagori SA, Jethwa BA. Fabrication and evaluation of bi - layer tablet containing conventional paracetamol and modified release diclofenac sodium. Indian journal of pharmaceutical sciences. 2010; 72(2):191.
Remya PN, Damodharan N, Kumar CV. Formulation and evaluation of bilayered tablets of Ibuprofen and methocarbamol. Int J PharmTech Res. 2010; 2(2):1250 - 55.
John AS, Sathesh BP, Divakar G, Jangid MK, Purohit KK. Development and evaluation of Sachin S. Kale*, Viraj S. Saste, Prajkta L. Ughade, Dheeraj T. Baviskar drug delivery system for atorvastatin calcium. J ournal of current pharmaceutical research. 2010; 1:31 - 8.
Nagaraju R, Kaza R. Formulation and evaluation of bilayer sustained release tablets of salbutamol and theophylline. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN). 2009; 2(3):638 - 46.
Rathod RT, Misra D. FDC of montelukast with levocetirizine: focus on bilayer technology. Journal of the Indian Medical Association. 2009; 107(8):562 - 4.
Kohlrausch A, inventor; Boehringer Ingelheim International GmbH, assignee. Bilayer tablet of telmisartan and simvastatin. United States patent application US 11/236,911. 2006 Apr 13.
Kulkarni A, Bhatia M. Development and evaluation of regioselective bilayer floating tablets of Atenolol and Lovastatin for biphasic release profile. Iranian J Pharm Res. 2009;8(1) : 15 - 25.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Irfan Inamdar, Syed Iftequar Ahmed
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at